36 completed. 36 Phase 2, 4 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 36 | Completed 36 |
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 3 | Completed 3 |
Follow Encephalitis: new trials by email Literature Review of Encephalitis trials Research Report on Encephalitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults GBP560-A, GBP560-B, IXIARO - Japanese Encephalitis Virus Disease | Phase 1 / Phase 2 | Completed | SK Bioscience Co., Ltd. | 161 | 2025-02-24 | 2026-09-11 |
| Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis IA session, Rituximab - Anti-NMDAR Encephalitis | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 20 | 2021-06-23 | 2026-08-10 |
| MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients Lenalidomide 10 mg, Placebo - Cognitive Impairment, Mild, Cognitive Dysfunction | Phase 2 | Completed | St. Joseph's Hospital and Medical Center, Phoenix | 15 | 2020-07-22 | 2026-06-10 |
| EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study Placebo, EG-501 - Neuropsychiatric Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE) | Phase 2 | Completed | Evergreen Therapeutics, Inc. | 131 | 2018-08-23 | 2025-12-15 |
| Treatment With Tamoxifen in Cryptococcal Meningitis Tamoxifen, Amphotericin B, Fluconazole - Meningitis Streptococcal, Hiv | Phase 2 | Completed | Oxford University Clinical Research Unit, Vietnam | 50 | 2017-10-10 | 2019-12-02 |
| Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age JEVAX, JECEVAX - Japanese Encephalitis | Phase 2 | Completed | National Institute of Hygiene and Epidemiology, Vietnam | 220 | 2017-06-02 | 2018-09-17 |
| IL-2 in Refractory Autoimmune Encephalitis Proleukin - Encephalitis | Phase 1 / Phase 2 | Completed | Seoul National University Hospital | 10 | 2016-03-01 | 2021-09-29 |
| Safety and Immunogenicity of JECEVAX in Young Children JEVAX, JECEVAX-1, JECEVAX-0.8 - Japanese Encephalitis | Phase 2 | Completed | National Institute of Hygiene and Epidemiology, Vietnam | 200 | 2015-04-01 | 2016-06-28 |
| New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly FSME-immune - Tick-borne Encephalitis | Phase 2 / Phase 3 | Completed | Sormland County Council, Sweden | 250 | 2015-01-01 | 2021-02-10 |
| Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients TBE virus vaccine - Tick Borne Encephalitis | Phase 2 | Completed | Medical University of Vienna | 34 | 2014-07-01 | 2022-02-03 |
| Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis Stem cell transplantation - Encephalitis, Meningitis | Phase 1 / Phase 2 | Completed | Vinmec Research Institute of Stem Cell and Gene Technology | 22 | 2014-06-16 | 2024-06-06 |
| The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans Japanese Encephalitis vaccine, Yellow Fever vaccine - Yellow Fever, Encephalitis, Japanese | Phase 2 | Completed | Singapore General Hospital | 84 | 2013-10-01 | 2016-04-20 |
| Humoral Response to Tick-borne Encephalitis Vaccine in Elderly FSME-immune - Tick-borne Encephalitis | Phase 2 / Phase 3 | Completed | Sormland County Council, Sweden | 200 | 2011-09-01 | 2015-11-18 |
| Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)] - Japanese Encephalitis | Phase 2 | Completed | University of Liverpool | 22 | 2009-05-01 | 2013-05-21 |
| Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults ChimeriVax-WN02 vaccine, Placebo - West Nile Fever | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 479 | 2008-10-01 | 2015-04-03 |
| Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine Inactivated, Dried, TSI-GSD 104, EEE - Eastern Equine Encephalitis | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 138 | 2008-06-03 | 2019-09-24 |
| Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine Eastern Equine Encephalitis Vaccine, Inactivated, Dried, TSI-GSD 104 - Eastern Equine Encephalitis | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 138 | 2008-06-03 | 2020-03-17 |
| Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28), Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28) - Japanese Encephalitis, Hepatitis A | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 300 | 2008-03-01 | 2014-10-02 |
| Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age ChimeriVax™-JE, Japanese Encephalitis Inactivated Mouse Brain Vaccine - Japanese Encephalitis | Phase 2 | Completed | Sanofi | 96 | 2007-01-01 | 2012-08-27 |
| Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults ChimeriVax-WN02 Low Dose, ChimeriVax-WN02 Medium Dose, ChimeriVax-WN02 High Dose - West Nile Fever | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 208 | 2005-12-01 | 2016-04-14 |
Showing 20 of 36. Sign in to see all of them.
Encephalitis, Japanese (12) · Encephalitis, Tick-Borne (8) · HIV Infections (4) · Acquired Immunodeficiency Syndrome (3) · Leukoencephalopathy, Progressive Multifocal (3) · Cognitive Dysfunction (2) · Encephalomyelitis, Eastern Equine (2) · Meningitis (2) · Myelitis (2) · West Nile Fever (2) · Yellow Fever (2) · AIDS-Related Opportunistic Infections (1) · Alzheimer Disease (1) · Anti-N-Methyl-D-Aspartate Receptor Encephalitis (1)
Brain Diseases (36) · Central Nervous System Diseases (36) · Nervous System Diseases (36) · Neuroinflammatory Diseases (36) · Central Nervous System Infections (32) · Infections (32) · Central Nervous System Viral Diseases (29) · RNA Virus Infections (29) · Virus Diseases (29) · Encephalitis, Viral (27) · Infectious Encephalitis (27) · Arbovirus Infections (24) · Encephalitis, Arbovirus (24) · Vector Borne Diseases (24)
Vaccines (3) · Desiccation (2) · Japanese Encephalitis Vaccines (2) · Saline Solution (2) · Amphotericin B (1) · Atovaquone (1) · Clarithromycin (1) · Cytarabine (1) · Didanosine (1) · Enfuvirtide (1) · FSME-IMMUN vaccine (1) · Filgrastim (1) · Fluconazole (1) · Hepatitis A Vaccines (1) · Immunoglobulins, Intravenous (1)
Pfizer (5) · Sanofi (5) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Sanofi Pasteur, a Sanofi Company (3) · National Institute of Hygiene and Epidemiology, Vietnam (2) · Sormland County Council, Sweden (2) · U.S. Army Medical Research and Development Command (2) · Assistance Publique - Hôpitaux de Paris (1) · Evergreen Therapeutics, Inc. (1) · French National Agency for Research on AIDS and Viral Hepatitis (1) · Medical University of Vienna (1) · National Institutes of Health Clinical Center (CC) (1) · Novartis (1) · Oxford University Clinical Research Unit, Vietnam (1) · SK Bioscience Co., Ltd. (1)
United States (12) · Australia (4) · Austria (4) · Germany (4) · Vietnam (4) · Finland (2) · France (2) · Sweden (2) · Thailand (2) · Canada (1) · India (1) · Nepal (1) · New Zealand (1) · Singapore (1)
Robert Rivard, MD (2) · Thiem D Vu, MD., PhD. (2) · Ulrich Behre, MD (2) · Ajit Rayamajhi, MBBS, MD (1) · Anand Dubey, M.D (1) · Atul Shanker, Dr. (1) · Bakul B. Javadekar, M.D. (1) · Boris Decourt, PhD (1) · Chirgwin K (1) · Christina Forstner, MD (1) · Dominique Costagliola (1) · Hall C (1)
PMID 20856164, PMID 20864814, PMID 21148499, PMID 21150279, PMID 21738597, PMID 24884681, PMID 25872531, PMID 25886645, PMID 27686833, PMID 27815383, PMID 28296863, PMID 28403842, PMID 30801037, PMID 32728481, PMID 33899755, PMID 34452033, PMID 34581270, PMID 35101266
2005 (1), K01AG047279 (1), R01AG059008 (1)